Evidence map›Paper›PMID 37405956›Full record

ArticleCancer communications (London, England)2023

HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progression.

Lin He, Hao Li, Can Li, Ze-Kun Liu, Meng Lu, Ren-Yu Zhang, Dong Wu, Ding Wei, Jie Shao, Man Liu and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cancer communications (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Ubiquitination in hepatocellular carcinoma immunity.Journal of translational medicine · 2025
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. NInternational journal of biological sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Lin He *National Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Hao Li *National Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Can Li *National Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Ze-Kun Liu *National Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.ORCID 0000-0002-4670-2628
Meng LuNational Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Ren-Yu ZhangNational Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Dong WuNational Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Ding WeiNational Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Jie ShaoNational Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Man LiuNational Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Hao-Lin WeiNational Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Cong ZhangNational Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Zhe WangState Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Ling-Min KongNational Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Zhi-Nan ChenNational Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.
Huijie BianNational Translational Science Centre for Molecular Medicine & Department of Cell Biology, Fourth Military Medical University, Xi'an, Shaanxi, P. R. China.ORCID 0000-0003-4690-4622
Air Force Medical University · CNCommand Hospital · INXijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mechanism of hepatitis B virus (HBV)-induced carcinogenesis remains an area of interest. The accumulation of hepatitis B surface antigen in the endoplasmic reticulum (ER) of hepatocytes stimulates persistent ER stress. Activity of the unfolded protein response (UPR) pathway of ER stress may play an important role in inflammatory cancer transformation. How the protective UPR pathway is hijacked by cells as a tool for malignant transformation in HBV-related hepatocellular carcinoma (HCC) is still unclear. Here, we aimed to define the key molecule hyaluronan-mediated motility receptor (HMMR) in this process and explore its role under ER stress in HCC development.

methodsAn HBV-transgenic mouse model was used to characterize the pathological changes during the tumor progression. Proteomics and transcriptomics analyses were performed to identify the potential key molecule, screen the E3 ligase, and define the activation pathway. Quantitative real-time PCR and Western blotting were conducted to detect the expression of genes in tissues and cell lines. Luciferase reporter assay, chromatin immunoprecipitation, coimmunoprecipitation, immunoprecipitation, and immunofluorescence were employed to investigate the molecular mechanisms of HMMR under ER stress. Immunohistochemistry was used to clarify the expression patterns of HMMR and related molecules in human tissues.

resultsWe found sustained activation of ER stress in the HBV-transgenic mouse model of hepatitis-fibrosis-HCC. HMMR was transcribed by c/EBP homologous protein (CHOP) and degraded by tripartite motif containing 29 (TRIM29) after ubiquitination under ER stress, which caused the inconsistent expression of mRNA and protein. Dynamic expression of TRIM29 in the HCC progression regulated the dynamic expression of HMMR. HMMR could alleviate ER stress by increasing autophagic lysosome activity. The negative correlation between HMMR and ER stress, positive correlation between HMMR and autophagy, and negative correlation between ER stress and autophagy were verified in human tissues.

conclusionsThis study identified the complicated role of HMMR in autophagy and ER stress, that HMMR controls the intensity of ER stress by regulating autophagy in HCC progression, which could be a novel explanation for HBV-related carcinogenesis.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAnimalsCarcinogenesisDNA-Binding ProteinsEndoplasmic Reticulum StressExtracellular Matrix ProteinsHepatitis B virusHumansHyaluronan ReceptorsMiceMice, TransgenicTranscription FactorsDNA-Binding ProteinsExtracellular Matrix Proteinshyaluronan-mediated motility receptorHyaluronan ReceptorsTranscription FactorsTRIM29 protein, humanautophagyendoplasmic reticulum stresshepatitis B virushepatocellular carcinomaHMMRTRIM29ubiquitination and proteasomal degradation

Identifiers

PMID37405956
PMCPMC10508155
OpenAlexW4383198900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.